BBHC
TNDM icon

Brown Brothers Harriman & Co’s Tandem Diabetes Care TNDM Stock Holding History

Brown Brothers Harriman & Co’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-780
Closed -$69 – 1210
2021
Q1 		$69 Buy
+780
New +$72.5K ﹤0.01% 590

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Brown Brothers Harriman & Co's TNDM Position: Q2 2021 in Review

Brown Brothers Harriman & Co sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 780 shares — an estimated $69 sold.

Brown Brothers Harriman & Co first reported a position in TNDM in Q1 2021 and held it in 1 quarter. The position peaked at $69 in Q1 2021. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Brown Brothers Harriman & Co reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 780 Tandem Diabetes Care shares in Q2 2021, an estimated $69.
  • Brown Brothers Harriman & Co first reported a position in Tandem Diabetes Care in Q1 2021 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Tandem Diabetes Care position peaked at $69 in Q1 2021.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2021, filed 13 Aug 2021.